Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Investigational New Drugs
|
January 1, 1996
Phase II trial of edatrexate in patients with metastatic colorectal cancer
G H Clamon, C E Riggs, R Dreicer, et al.
Bone Marrow Transplantation
|
July 1, 1995
Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation
C K Lee, R D Gingrich, R J Hohl, et al.
Bone Marrow Transplantation
|
September 1, 1996
Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment
C K Lee, G S Harman, R J Hohl, et al.
Bioorganic & Medicinal Chemistry
|
November 1, 2000
Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside
K Y Jung, R J Hohl, A J Wiemer, et al.
Blood
|
December 15, 1996
Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras
F Goldman, R J Hohl, J Crabtree, et al.
Lipids
|
February 21, 1998
Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids
R J Hohl, K A Lewis, D M Cermak, et al.
Bioorganic & Medicinal Chemistry
|
July 29, 1998
Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase
S A Holstein, D M Cermak, D F Wiemer, et al.
Clinical Pharmacology and Therapeutics
|
June 22, 2011
Clinical pharmacology as a foundation for translational science
S A Waldman, R J Hohl, G L Kearns, et al.
American Journal of Hematology
|
November 3, 1998
Low pulse oximeter-measured hemoglobin oxygen saturations with hemoglobin Cheverly
R J Hohl, A R Sherburne, J E Feeley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2001
Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway
S Chapel, P Veng-Pedersen, R J Hohl, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Investigational New Drugs
|
January 1, 1996
Phase II trial of edatrexate in patients with metastatic colorectal cancer
G H Clamon, C E Riggs, R Dreicer, et al.
Bone Marrow Transplantation
|
July 1, 1995
Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation
C K Lee, R D Gingrich, R J Hohl, et al.
Bone Marrow Transplantation
|
September 1, 1996
Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment
C K Lee, G S Harman, R J Hohl, et al.
Bioorganic & Medicinal Chemistry
|
November 1, 2000
Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside
K Y Jung, R J Hohl, A J Wiemer, et al.
Blood
|
December 15, 1996
Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras
F Goldman, R J Hohl, J Crabtree, et al.
Lipids
|
February 21, 1998
Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids
R J Hohl, K A Lewis, D M Cermak, et al.
Bioorganic & Medicinal Chemistry
|
July 29, 1998
Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase
S A Holstein, D M Cermak, D F Wiemer, et al.
Clinical Pharmacology and Therapeutics
|
June 22, 2011
Clinical pharmacology as a foundation for translational science
S A Waldman, R J Hohl, G L Kearns, et al.
American Journal of Hematology
|
November 3, 1998
Low pulse oximeter-measured hemoglobin oxygen saturations with hemoglobin Cheverly
R J Hohl, A R Sherburne, J E Feeley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2001
Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway
S Chapel, P Veng-Pedersen, R J Hohl, et al.
Page
of 5